OSCR Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

03
Prezzo $30.94
P/E (TTM) 21.3
EPS (TTM) $1.45
Ricavi (TTM) $15.32B
ROE (TTM) 34.3%
D/E Debito/Patrimonio (MRQ) 0.2
Intervallo 52 sett. $11–$34

OSCR Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

04
intervallo
barre

La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.

Informazioni su Oscar Health, Inc. Class A Common Stock Panoramica della società da Wikipedia

05 · wikidata

Oscar Management Corporation, doing business as Oscar Health is an American for-profit health insurance company, founded in 2012 by Joshua Kushner, Kevin Nazemi and Mario Schlosser, and is headquartered in New York City. The company sells health insurance and additionally provides other services in the health insurance industry through telemedicine, healthcare focused technological interfaces, and transparent claims pricing systems.

History

2012–2015

According to the company, it was founded in 2012 by Mario Schlosser, Joshua Kushner, and Kevin Nazemi, who were classmates at Harvard Business School. Mother Jones reported in March 2020 that Kushner and his brother, Jared, owned the firm's parent company, Thrive Partners III, at the time of its incorporation in 2013. Oscar began selling insurance for 2013, the same year that the Affordable Care Act exchanges and individual mandate went into effect for the 2014 plan year. In its first year, Oscar secured 16,000 members. In 2015, Oscar expanded coverage to New Jersey and grew to about 40,000 members.

2016

Oscar had 145,000 members in New York, New Jersey, California, and Texas in 2016. The firm expanded its operations to Tempe, Arizona, in August that year, where it decided to locate its Concierge teams, their name for their member services model. On August 23, Oscar announced it would be exiting the New Jersey Marketplace at the end of 2016, citing uncertainties in the market that would make it challenging "to operate effectively and continue to deliver access to quality healthcare." Oscar also announced that it would halve the size of its provider network in New York amidst rising premiums in order to "gain more control over pricing and patient experience".

In November 2016, the firm opened the Oscar Center in partnership with Mount Sinai Health System. Located in Brooklyn Heights, next to the Jay Street–MetroTech station, the Oscar Center had a primary care practice only available to Oscar policyholders, with a doctor, nurse practitioner, and a behavioral health specialist. It also hosted free classes for members, such as yoga classes or classes for expectant mothers. On March 13, 2020, Oscar closed the Oscar Center "until further notice."

2017

On April 25, 2017, Oscar announced its entrance into the small group insurance market, offering health plans in New York. On June 15, 2017, Oscar announced its partnership with Cleveland Clinic to offer individual health insurance plans to consumers in five counties in Northeastern Ohio.

On June 21, 2017, Oscar announced its intention to expand to additional markets in 2018 in areas of Tennessee, Ohio, Texas, New Jersey and California. On July 12, 2017, Oscar announced that it would be selling small group insurance in the Nashville metro area to companies with up to 50 employees through a strategic partnership with Humana.

A report by the New York Times in October 2017 speculated that Oscar Health had ties to Saudi Arabia. That month, Jared and Joshua Kushner visited Saudi Arabia's Crown Prince Mohammed bin Salman within days of each other. Despite Jared severing ties with Thrive Partners when he began working for the Trump administration, these coordinated visits raised questions about his ability to be impartial on Saudi affairs. Five months after Kushner's visit to Saudi Arabia in October 2017, Oscar Health announced a $165 million round of financing.

While a spokesman for Kushner said that Oscar Health's management didn't know of direct investment by the Saudis, he declined to disclose if Saudis had invested in Thrive funds. He only confirmed that Thrive hadn't received money from any Saudi parties since the presidential election. In May 2018, Jared Kushner disclosed $8.2 million in capital gains from Thrive funds.

2020–present

In January 2020, Oscar announced a partnership with Cigna to bring health insurance plans to small businesses. The partnership, Cigna + Oscar, will "launch in select markets in 2020 and plan to expand the partnership over time."

As of June 2020, Oscar had sold individual health insurance plans, both directly and through health insurance marketplaces, in New York, Texas and California. Oscar sells Medicare Advantage plans in New York City and Houston, Texas. Mario Schlosser is the company's CEO, after serving as Co-CEO with Nazemi until the latter's departure in early 2015. While Kushner does not hold a formal role in Oscar's daily operations, he remains a major shareholder and Schlosser confirmed (as of 2017) that he has "significant input in multiple aspects of the company like strategy, hiring, and marketing."

Oscar Health raised $1.2 billion on March 3, 2021, after an IPO.

Oscar Health reported 1.1 million members across its platform, which equates to 1 in 13 ACA exchange-based enrollees. The company announced it would exit the Arkansas and Colorado markets for plan year 2023.

Mario Schlosser steps down as CEO on April 3, 2023, transitioning to President of Technology. Mark Bertolini takes over as CEO.

In 2025, Oscar Health was ranked 437th by revenue on the Fortune 500 list and 42nd within the healthcare sector in the same rankings.

Marketing and brand

Oscar Health has run marketing campaigns on the New York City Subway. Bloomberg News reported the advertising campaigns feature cartoons suggesting "an easier way of getting medical care." AdWeek described Oscar Health's print ads as featuring "whimsical, animated characters".

In 2015, AdWeek reported that Oscar was airing its first television campaign targeted at the demographics of "new parents who are too frazzled to shop for health insurance." The ad launched on network stations in New Jersey and New York areas, cable, movie theaters located in New Jersey and in advertising within the Spotify app.

In 2016, Oscar ran a subway ad campaign with an educational bent around what the problems are with the American healthcare system.

Finances

Funding

Oscar has raised capital through a series of funding rounds. Its investors include Thrive Capital, General Catalyst Partners, Khosla Ventures, CapitalG, and Fidelity Investments.

During the May 2014 Series A round, Peter Thiel's Founders Fund led the series investing $30 million. By the close of Series A, Forbes reported the valuation of the company at $800 million.

During the 2015 Series B round, Oscar Health raised $145 million, bringing the total capital raised to $300 million, thus valuing the company at $1.5 billion. Series B investors included Formation 8, Horizons Ventures, Wellington Management Company, and Goldman Sachs.

In September 2015, Oscar announced a funding round with Google Ventures and Google Capital, valuing the company at $1.75 billion.

During the 2016 Series C round, Oscar raised $400 million led by Fidelity Investments, with secondary participation from previous investors, with a reported valuation of $2.7 billion. In 2018, Alphabet invested $375 million in Oscar Health. As of 2019, the company had raised $1.3 billion, and was valued at $3.2 billion.

In June 2020, Oscar raised $225 million in funding, in which the funding round saw participation from previous investors and also new investors, namely Baillie Gifford and Coatue.

Revenue

In 2014, New York magazine reported that as of May 2014, Oscar Health had 16,000 subscribers enrolled in its insurance program producing an estimated $72 million. In 2015, Forbes reported that Oscar Health had 40,000 subscribers with an average subscriber paying annual fees of $4,500, placing Oscar Health's revenue estimates at $180 million.

Vox reported that in 2015, Oscar Health lost $92.4 million in New York as the firm's analytical models failed to accurately forecast "the people who signed up for coverage were sicker than the company had expected."

By 2016, Oscar Health had 135,000 subscribers, with roughly half residing in New York State.

In February 2017, Bloomberg reported that Oscar had lost $204.9 million in 2016.

In May 2017, Bloomberg reported that Oscar's first quarter loss had narrowed by nearly half, writing that the company was "beginning to get a handle on its medical costs." In August 2017, Bloomberg also reported that Oscar had posted a $57.6 million loss in the first half of 2017, down from the $83 million lost posted the year prior.

In December 2017, TechCrunch reported that Oscar would expect to generate $1 billion in revenue and enroll 250,000 in 2018.

In January 2020, TechCrunch reported that Oscar served 400,000 members and expected to bring in $2 billion by the end of the year.

Headquarters and offices

Oscar's headquarters are located in Tribeca, New York City. They also have a technology outpost in Los Angeles and a member services operation in Tempe, Arizona.

Fonte: Wikipedia (Inglese), CC BY-SA 4.0 · Vedi su Wikipedia ↗

Wikidata ↗

settoreFinancials industriaInsurance dipendenti2.305 paeseUS

Performance decennale Andamento di ricavi, utile netto, margini e EPS

06
Ricavi$11.70B
2019-12-31 → 2025-12-31
EPS$-1.69
2019-12-31 → 2025-12-31
Flusso di cassa libero$1.06B
2021-12-31 → 2025-12-31
Margine netto3.6%
2021-12-31 → 2025-12-31
Valutazione e Rapporti 07–12

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica Tendenza 5 anni OSCR media 5 anni Mediana dei peer Verdetto
P/E (TTM) 21.3media 5 anni ≈23.0 ≈23.0 15.4 Sopravvalutato

La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.

valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

14
Sorpresa media 24.3%
Prossimo report Nov 04, 2026
PeriodoRapportoEPS ActualEPS StimatoSorpresa
30 Giugno 2026 Ago 6, 2026 $1.10 $0.39 179.5%
31 Marzo 2026 $2.07 $1.21 71.5%
31 Dicembre 2025 $-1.24 $-0.91 -37.0%
30 Settembre 2025 $-0.53 $-0.57 6.6%
30 Giugno 2025 $-0.89 $-0.47 -88.5%
31 Marzo 2025 $0.92 $0.81 13.8%

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

15
Conto Economico 13
Metrica Tendenza 202520242023202220212020
Revenue $11.70B$9.18B$5.86B$3.96B$1.84B$463M
SG&A Expense $2.05B$1.76B$1.43B$1.26B$265M$167M
Operating Income $-396M$57M$-236M$-590M$-544M$-402M
Interest Expense ··$25M$23M$5M$4M
Other Non-op $-23M$-105.0K$-7M$2M$-1M·
Pretax Income $-437M$33M$-267M$-610M$-571M$-406M
Income Tax $6M$7M$3M$-523.0K$846.0K$1M
Net Income $-443M$25M$-271M$-606M$-573M$-407M
EPS (Basic) $-1.69$0.11$-1.22$-2.85$-3.20$-14.16
EPS (Diluted) $-1.69$0.10$-1.22$-2.85$-3.20$-14.16
Shares (Basic) 262,388,000240,386,000221,655,000212,475,000178,967,05629,263,424
Shares (Diluted) 262,388,000265,853,000221,655,000212,475,000178,967,05629,263,424
EBITDA $-367M$89M$-205M·$-530M·
Stato Patrimoniale 23
Metrica Tendenza 202520242023202220212020
Cash & Equivalents $2.77B$1.53B$1.87B$1.56B$1.10B$826M
Short-term Investments ·$624M$690M···
Receivables $363M·····
Other Current Assets $24M$21M$7M$6M$4M·
Current Assets $4.61B$2.85B$3.06B$4.12B$2.31B$1.87B
PP&E (Net) $88M$67M$62M$60M$47M$36M
PP&E (Gross) $230M$181M$150M$117M$89M$63M
Accum. Depreciation $142M$114M$88M$57M$42M$27M
Other Non-current Assets $120M$82M$83M$95M$97M$13M
Total Assets $6.33B$4.84B$3.60B$4.53B$3.32B$2.27B
Accounts Payable $507M$432M$273M$298M$235M$138M
Current Liabilities $4.86B$3.46B$2.43B$3.26B$1.85B$1.67B
Capital Leases $52M$61M$67M$72M$77M·
Other Non-current Liabilities $52M$61M$68M$72M$77M$0
Total Liabilities $5.34B$3.82B$2.80B$3.63B$1.93B$1.82B
Total Debt $430M$300M$299M·$0·
Common Stock ·····$2.0K
Paid-in Capital $4.26B$3.87B$3.68B$3.51B$3.39B$133M
Retained Earnings $-3.29B$-2.85B$-2.88B$-2.61B$-2.00B$-1.43B
Treasury Stock $3M$3M$3M$3M$3M$3M
AOCI $18M$-2M$1M$-10M$-4M$879.0K
Stockholders' Equity $978M$1.01B$804M$890M$1.39B$-1.30B
Liabilities + Equity $6.33B$4.84B$3.60B$4.53B$3.32B$2.27B
Flusso di cassa 16
Metrica Tendenza 202520242023202220212020
D&A $29M$32M$31M$15M$15M$11M
Stock-based Comp $88M$110M$160M$112M$86M$36M
Deferred Tax $2M$-2M$58.0K$-165.0K$-101.0K$-67.0K
Other Non-cash $1.42B$813M$-192M·$290M·
Operating Cash Flow $1.09B$978M$-272M$380M$-182M$223M
CapEx $36M$28M$26M$29M$26M$14M
Investing Cash Flow $-241M$-1.39B$577M$-227M$-775M$-345M
Debt Issued $410M$0$0$305M$0$147M
Net Debt Issued $410M$0$0···
Stock Repurchased ····$0$0
Net Stock Activity ····$0·
Financing Cash Flow $399M$68M$6M$301M$1.24B$612M
Net Change in Cash $1.25B$-341M$311M$455M$282M$490M
Taxes Paid $18M$674.0K$2M$2M$697.0K$2M
Free Cash Flow $1.06B$950M$-298M·$-208M·
Levered FCF ··$-323M·$-212M·
Redditività 7
Metrica Tendenza 202520242023202220212020
Operating Margin -3.4%0.62%-4.0%·-29.6%·
Net Margin -3.8%0.28%-4.6%·-31.1%·
Pretax Margin -3.7%0.36%-4.6%·-31.0%·
EBITDA Margin -3.1%0.97%-3.5%·-28.8%·
ROA -7.9%0.60%-6.7%·-20.5%·
ROE -44.5%2.8%-32.0%·-36.7%·
ROIC -28.5%3.4%-21.6%·-39.3%·
Liquidità e Solvibilità 5
Metrica Tendenza 202520242023202220212020
Current Ratio 0.90.81.3·1.2·
Quick Ratio 0.60.60.8·0.6·
Debt / Equity 0.40.30.4·0.0·
LT Debt / Equity 0.40.30.4·0.0·
Interest Coverage ··-9.6·-115.4·
Efficienza 1
Metrica Tendenza 202520242023202220212020
Asset Turnover 2.12.21.4·0.7·
Per Azione 3
Metrica Tendenza 202520242023202220212020
Revenue / Share $44.60$34.52$26.45·$10.27·
Cash Flow / Share $4.17$3.68$-1.23·$-1.02·
EPS (TTM) $-1.69$0.10$-1.22$-2.85$-3.20·
Tassi di Crescita 3
Metrica Tendenza 202520242023202220212020
Revenue YoY 27.5%56.5%47.9%115.6%297.3%·
Revenue CAGR 3Y 43.5%70.9%133.1%···
Revenue CAGR 5Y 90.8%·····
Valutazione (TTM) 4
Metrica Tendenza 202520242023202220212020
Revenue TTM $11.70B$9.18B$5.86B$3.96B$1.84B·
Net Income TTM $-443M$25M$-271M$-606M$-573M·
P/E -8.5134.4-7.5-0.9-2.5·
Earnings Yield -11.8%0.74%-13.3%-115.9%-40.8%·

Periodo più recente a sinistra · valori nulli mostrati come ·

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

16
Metrica 2025-12-312024-12-312023-12-312022-12-312021-12-31
Ricavi $11.70B $9.18B $5.86B $3.96B $1.84B
Margine Operativo % -3.4% 0.62% -4.0% · -29.6%
Utile netto $-443M $25M $-271M $-606M $-573M
EPS Diluito $-1.69 $0.10 $-1.22 $-2.85 $-3.20

Proprietari istituzionali (13F) 459 filer · $6.2B totale · Aggiornato al 30 Settembre 2026

17

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Detentori 459
Valore detenuto $6.2B
Nuove posizioni 125
Posizioni chiuse 46
Attività istituzionale — Q2 2026 vs trimestre precedente
Nuove posizioni Posizioni chiuse Aumentato Diminuito Variazione netta delle azioni
125 (+51 vs trimestre precedente) 46 (-18 vs trimestre precedente) 147 (+22 vs trimestre precedente) 115 (+3 vs trimestre precedente) +22.8M

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione Valore Azioni % di 13F tracciati Tipo
BlackRock, Inc. $587.153.449 20.587.428 9,50% Azioni
D. E. Shaw & Co., Inc. $360.595.957 12.643.617 5,84% Azioni
VANGUARD PORTFOLIO MANAGEMENT LLC $314.559.172 11.029.424 5,09% Azioni
VANGUARD CAPITAL MANAGEMENT LLC $301.725.543 10.579.437 4,88% Azioni
VANGUARD GROUP INC $297.476.962 20.701.250 4,82% Azioni
AMERICAN CENTURY COMPANIES INC $258.255.502 9.055.242 4,18% Azioni
JANE STREET GROUP, LLC $181.530.912 6.365.039 2,94% Azioni
Thrive Capital Management, LLC $180.919.957 6.343.617 2,93% Azioni
GEODE CAPITAL MANAGEMENT, LLC $165.994.311 5.819.186 2,69% Azioni
STATE STREET CORP $165.454.531 5.801.351 2,68% Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP $162.917.648 5.712.400 2,64% Opzione Call
FMR LLC $142.557.861 4.998.523 2,31% Azioni
CITADEL ADVISORS LLC $120.626.823 4.229.552 1,95% Azioni
TWO SIGMA INVESTMENTS, LP $115.097.850 4.035.689 1,86% Azioni
DIMENSIONAL FUND ADVISORS LP $101.885.043 3.571.731 1,65% Azioni
BIT Capital GmbH $97.480.134 3.417.957 1,58% Azioni
RENAISSANCE TECHNOLOGIES LLC $93.673.940 3.284.500 1,52% Azioni
JACOBS LEVY EQUITY MANAGEMENT, INC $86.282.012 3.025.316 1,40% Azioni
GLYNN CAPITAL MANAGEMENT LLC $73.462.615 2.575.828 1,19% Azioni
CITADEL ADVISORS LLC $72.469.320 2.541.000 1,17% Opzione Call
GOLDMAN SACHS GROUP INC $65.298.165 2.289.557 1,06% Azioni
NORTHERN TRUST CORP $63.063.680 2.211.209 1,02% Azioni
WOLVERINE ASSET MANAGEMENT LLC $61.825.656 2.167.800 1,00% Opzione Put
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $60.458.493 2.119.863 0,98% Azioni
MORGAN STANLEY $60.299.272 2.114.280 0,98% Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP $55.351.616 1.940.800 0,90% Opzione Put
JANE STREET GROUP, LLC $53.968.396 1.892.300 0,87% Opzione Call
Nuveen, LLC $50.501.648 1.770.745 0,82% Azioni
BlackBarn Capital Partners LP $49.910.000 1.750.000 0,81% Opzione Put
BNP PARIBAS FINANCIAL MARKETS $48.660.710 1.706.196 0,79% Azioni
VANGUARD FIDUCIARY TRUST CO $45.996.029 1.612.764 0,74% Azioni
CITADEL ADVISORS LLC $44.459.828 1.558.900 0,72% Opzione Put
STATE OF MICHIGAN RETIREMENT SYSTEM $41.354.000 1.450.000 0,67% Azioni
BANK OF AMERICA CORP /DE/ $37.594.294 1.318.173 0,61% Azioni
Assenagon Asset Management S.A. $35.592.732 1.247.992 0,58% Azioni
TWO SIGMA ADVISERS, LP $35.534.136 2.472.800 0,58% Azioni
UBS Group AG $34.596.357 1.213.056 0,56% Azioni
JANE STREET GROUP, LLC $33.796.200 1.185.000 0,55% Opzione Put
GROUP ONE TRADING LLC $32.744.154 1.148.112 0,53% Azioni
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND $31.200.652 1.093.992 0,51% Azioni
Qube Research & Technologies Ltd $30.913.940 1.083.939 0,50% Azioni
TUDOR INVESTMENT CORP ET AL $29.055.948 1.018.792 0,47% Azioni
GILDER GAGNON HOWE & CO LLC $28.576.515 1.001.982 0,46% Azioni
JPMORGAN CHASE & CO $26.387.407 885.558 0,43% Azioni
FEDERATED HERMES, INC. $26.096.200 915.014 0,42% Azioni
WELLS FARGO & COMPANY/MN $23.408.907 820.789 0,38% Azioni
Walleye Capital LLC $23.243.058 814.974 0,38% Azioni
Point72 Asset Management, L.P. $22.809.212 799.762 0,37% Azioni
Walleye Trading LLC $22.744.700 797.500 0,37% Opzione Call
Bank of New York Mellon Corp $22.032.138 772.515 0,36% Azioni

Mostra tutti i 459 proprietari istituzionali →

Attivisti e proprietari del 5%+ 2 partecipazioni

18

Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.

Depositante Depositato Partecipazione Stato Scopo Deposito
Claremount TW, L.P., Claremount V Associates, L.P., Claremount VI Associates, L.P., Claremount VII Associates, L.P., Joshua Kushner, Thrive Capital Partners II, L.P., Thrive Capital Partners III, L.P., Thrive Capital Partners V, L.P., Thrive Capital Partners VI Growth, L.P., Thrive Capital Partners VII Growth, L.P., Thrive Partners II GP, LLC, Thrive Partners III GP, LLC, Thrive Partners V GP, LLC, Thrive Partners VI GP, LLC, Thrive Partners VII GP, LLC, Thrive Partners VII Growth GP, LLC 18 Settembre 2026 12,10% Modifica · SEC
Thrive Capital Partners II, L.P. (2), Thrive Partners II GP, LLC (2), Thrive Capital Partners III, L.P. (2), Claremount TW, L.P. (2), Thrive Partners III GP, LLC (2), Thrive Capital Partners V, L.P. (2), Claremount V Associates, L.P. (2), Thrive Partners V GP, LLC (2), Thrive Capital Partners VI Growth, L.P. (2), Claremount VI Associates, L.P. (2), Thrive Partners VI GP, LLC (2), Thrive Capital Partners VII Growth, L.P. (2), Thrive Partners VII Growth GP, LLC (2), Claremount VII Associates, L.P. (2), Thrive Partners VII GP, LLC (2), Joshua Kushner (2) ×4 depositi 13 Novembre 2024 · Deposito iniziale · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Insider aziendali 23 insider · 12 dirigenti · 12 direttori

19
Insider Ruolo Ultima attività Azioni possedute Acquisti 12m Vendite 12m Netto 12m
Mark T Bertolini Chief Executive Officer 30 Giugno 2026 S 7.751.570 1 8 $-58.759.399
Richard Scott Blackley Chief Financial Officer 03 Settembre 2026 S 1.046.108 0 9 $-7.941.907
Janet Liang President, Oscar Insurance 03 Settembre 2026 S 248.697 0 5 $-821.072
Steven Wolin Chief Operating Officer 01 Dicembre 2024 M 102.598 0 0 $0
Meghan V. Joyce Chief Operating Officer 01 Marzo 2022 M 43.070 0 0 $0
Joshua Kushner Co-Founder and Vice Chairman 18 Settembre 2026 J 0 0 0 $0
Victoria Baltrus Chief Accounting Officer 03 Settembre 2026 S 213.631 0 5 $-194.480
Adam Mcananey Chief Legal Officer 03 Settembre 2026 S 209.004 0 5 $-783.513
Alessandrea C. Quane EVP, Chief Insurance Officer 05 Dicembre 2024 M 430.216 0 0 $0
Ranmali Bopitiya EVP & Chief Legal Officer 01 Dicembre 2024 M 241.488 0 0 $0
Dennis Weaver Chief Clinical Officer 01 Dicembre 2022 M 27.110 0 0 $0
Joel Klein Chief Policy & Strat. Officer 18 Agosto 2021 M 17 0 0 $0
Vanessa Ames Wittman Direttore 18 Settembre 2026 S 112.121 0 1 $-806.000
Mario Schlosser Direttore 03 Settembre 2026 S 449.444 0 29 $-68.790.950
William Gassen Direttore 09 Luglio 2026 A 82.840 0 0 $0
David Plouffe Direttore 09 Luglio 2026 A 137.121 0 0 $0
Sid Sankaran Direttore 09 Luglio 2026 A 22.609 0 0 $0
Laura W Lang Direttore 04 Giugno 2026 A 82.840 0 0 $0
Jeffery H Boyd Direttore 09 Aprile 2026 A 705.673 0 0 $0
Elbert O. Robinson Jr. Direttore 12 Maggio 2025 S 64.512 0 0 $0
Jr Charles E Phillips Direttore 14 Ottobre 2022 A 85.787 0 0 $0
Teri List-Stoll Direttore 05 Marzo 2021 A 50.000 0 0 $0
Ari Fischel · 05 Marzo 2021 A 0 0 0 $0

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Proprietà ETF Posseduti da 46 ETF

20

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo Peso Unità Aggiornato al Fonte
ABLS · Abacus FCF ETF Trust 5,83% 867 NS 31 Luglio 2026 N-PORT
PTH · Invesco Exchange-Traded Fund Trust 1,95% 188.213 SH 02 Ottobre 2026 Giornaliero
RNIN · EA Series Trust 1,20% 70.047 NS 31 Luglio 2026 N-PORT
FYC · First Trust Exchange-Traded AlphaDE… 0,74% 307.696 NS 31 Luglio 2026 N-PORT
JSML · Janus Detroit Street Trust 0,60% 69.666 NS 31 Luglio 2026 N-PORT
IWO · iShares Trust 0,52% 2.269.828 SH 11 Settembre 2026 Giornaliero
JSMD · Janus Detroit Street Trust 0,51% 171.181 NS 31 Luglio 2026 N-PORT
VTWG · VANGUARD SCOTTSDALE FUNDS 0,40% 258.034 SH 19 Agosto 2026 Giornaliero
DWAS · Invesco Exchange-Traded Fund Trust … 0,36% 48.469 SH 02 Ottobre 2026 Giornaliero
FYX · First Trust Exchange-Traded AlphaDE… 0,35% 152.933 NS 31 Luglio 2026 N-PORT
BKSE · BNY Mellon ETF Trust 0,31% 8.798 NS 31 Luglio 2026 N-PORT
BBSC · J.P. Morgan Exchange-Traded Fund Tr… 0,27% 61.099 NS 31 Luglio 2026 N-PORT
FYEE · Fidelity Greenwood Street Trust 0,27% 19.102 NS 31 Luglio 2026 N-PORT
IWM · iShares Trust 0,26% 6.175.602 SH 11 Settembre 2026 Giornaliero
FBUF · Fidelity Greenwood Street Trust 0,25% 1.889 NS 31 Luglio 2026 N-PORT
ISCG · iShares Trust 0,24% 71.367 SH 11 Settembre 2026 Giornaliero
RSSL · Global X Funds 0,24% 115.406 NS 31 Luglio 2026 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 0,21% 1.387.125 SH 19 Agosto 2026 Giornaliero
FHEQ · Fidelity Greenwood Street Trust 0,21% 61.010 NS 31 Luglio 2026 N-PORT
VBK · VANGUARD INDEX FUNDS 0,19% 3.171.535 SH 19 Agosto 2026 Giornaliero
DFAS · Dimensional ETF Trust 0,16% 805.292 NS 31 Luglio 2026 N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust 0,16% 145.781 SH 02 Ottobre 2026 Giornaliero
FAD · First Trust Exchange-Traded AlphaDE… 0,15% 27.872 NS 31 Luglio 2026 N-PORT
ESML · iShares Trust 0,11% 96.895 SH 11 Settembre 2026 Giornaliero
FNCL · FIDELITY COVINGTON TRUST 0,08% 61.975 NS 31 Luglio 2026 N-PORT
VB · VANGUARD INDEX FUNDS 0,08% 5.488.922 SH 19 Agosto 2026 Giornaliero
VFH · VANGUARD WORLD FUND 0,08% 384.466 SH 19 Agosto 2026 Giornaliero
WSML · iShares Trust 0,07% 14.630 SH 11 Settembre 2026 Giornaliero
VXF · VANGUARD INDEX FUNDS 0,07% 2.534.194 SH 19 Agosto 2026 Giornaliero
IUS · Invesco Exchange-Traded Self-Indexe… 0,04% 12.495 SH 02 Ottobre 2026 Giornaliero
DFSU · Dimensional ETF Trust 0,03% 20.892 NS 31 Luglio 2026 N-PORT
DCOR · Dimensional ETF Trust 0,02% 21.472 NS 31 Luglio 2026 N-PORT
DFAC · Dimensional ETF Trust 0,02% 286.808 NS 31 Luglio 2026 N-PORT
TILT · FlexShares Trust 0,02% 12.166 NS 31 Luglio 2026 N-PORT
DFAU · Dimensional ETF Trust 0,01% 50.403 NS 31 Luglio 2026 N-PORT
IWV · iShares Trust 0,01% 64.590 SH 11 Settembre 2026 Giornaliero
VTI · VANGUARD INDEX FUNDS 0,01% 7.601.113 SH 19 Agosto 2026 Giornaliero
VT · VANGUARD INTERNATIONAL EQUITY INDEX… 0,01% 194.738 SH 19 Agosto 2026 Giornaliero
VTHR · VANGUARD SCOTTSDALE FUNDS 0,01% 19.808 SH 19 Agosto 2026 Giornaliero
DFUS · Dimensional ETF Trust 0,01% 66.708 NS 31 Luglio 2026 N-PORT
ESGV · VANGUARD WORLD FUND 0,01% 53.203 SH 19 Agosto 2026 Giornaliero
ITOT · iShares Trust 0,01% 287.602 SH 11 Settembre 2026 Giornaliero
DXUV · Dimensional ETF Trust 0,00% 472 NS 31 Luglio 2026 N-PORT
IAK · iShares Trust · 117.671 SH 11 Settembre 2026 Giornaliero
ISCB · iShares Trust · 10.063 SH 11 Settembre 2026 Giornaliero
SMLF · iShares Trust · 286.871 SH 11 Settembre 2026 Giornaliero

OSCR Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

21
rating · 19 analisti COMPRA
Target mediano $33.50 +8,3%
2 10,5% Acquisto forte
7 36,8% Compra
9 47,4% Mantieni
1 5,3% Vendi
0 0,0% Vendita forte

Target Price a 12 Mesi

10 analisti · 2026-10-03

Target medio $35.40 +14,4%

Ora Prezzo attuale $30.94
Basso$26.00 Media$35.40 Alto$49.00

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

22

Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.

Ticker Capitalizzazione di Mercato P/E Rev YoY Margine Netto ROE Margine lordo
OSCR · -8.5 27.5% -3.8% -44.5% ·
AFL $57.20B 16.2 -9.3% 21.2% 12.9% ·
PRU · · · · · ·
PFG $19.18B 16.8 -3.1% 7.6% 10.3% ·
UNM · · · · · ·
GL $12.90B 9.9 3.7% 19.4% 20.4% ·
PRI $8.22B 11.3 6.6% 22.8% 31.9% ·
LNC $8.46B 7.6 -1.2% 6.5% 12.3% ·
CNO $4.01B 18.5 0.85% 5.1% 8.9% ·

Ultime notizie Notizie recenti che menzionano questa società

23

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

26

Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

Fonte: SEC 10-Q depositato Ago 7, 2026